Morgan Stanley’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $770K | Buy |
|
|||||
|
2025
Q1 | $38.5K | Buy |
|
|||||
|
2024
Q4 | $13.6K | Sell |
|
|||||
|
2024
Q3 | $59.4K | Sell |
|
|||||
|
2024
Q2 | $230K | Sell |
|
|||||
|
2024
Q1 | $1.87M | Buy |
|
|||||
|
2023
Q4 | $245K | Buy |
|
|||||
|
2023
Q3 | $82.1K | Sell |
|
|||||
|
2023
Q2 | $145K | Sell |
|
|||||
|
2023
Q1 | $229K | Buy |
|
|||||
|
2022
Q4 | $28.7K | Buy |
|
|||||
|
2022
Q3 | $22K | Sell |
|
|||||
|
2022
Q2 | $295K | Buy |
|
|||||
|
2022
Q1 | $206K | Sell |
|
|||||
|
2021
Q4 | $376K | Sell |
|
|||||
|
2021
Q3 | $601K | Sell |
|
|||||
|
2021
Q2 | $4.03M | Buy |
|
|||||
|
2021
Q1 | $83K | Sell |
|
|||||
|
2020
Q4 | $1.98M | Buy |
|
|||||
|
2020
Q3 | $52K | Sell |
|
|||||
|
2020
Q2 | $216K | Sell |
|
|||||
|
2020
Q1 | $206K | Sell |
|
|||||
|
2019
Q4 | $557K | Buy |
|
|||||
|
2019
Q3 | $187K | Sell |
|
|||||
|
2019
Q2 | $3.71M | Buy |
|
|||||
|
2019
Q1 | $1.23M | Buy |
|
|||||
|
2018
Q4 | $1.27M | Sell |
|
|||||
|
2018
Q3 | $1.78M | Sell |
|
|||||
|
2018
Q2 | $2.53M | Sell |
|
|||||
|
2018
Q1 | $3.82M | Buy |
|
|||||
|
2017
Q4 | $2.1M | Sell |
|
|||||
|
2017
Q3 | $3.56M | Buy |
|
|||||
|
2017
Q2 | $1.14M | Buy |
|
|||||
|
2017
Q1 | $916K | Sell |
|
|||||
|
2016
Q4 | $701K | Buy |
|
|||||
|
2016
Q3 | $75K | Buy |
|
|||||
|
2016
Q2 | $12K | Buy |
|
|||||
|
2016
Q1 | $13K | Sell |
|
|||||
|
2015
Q4 | $123K | Buy |
|